CG Oncology Relocates HQ, Hints at Officer/Director Changes
Ticker: CGON · Form: 8-K · Filed: Nov 26, 2025 · CIK: 1991792
| Field | Detail |
|---|---|
| Company | Cg Oncology, Inc. (CGON) |
| Form Type | 8-K |
| Filed Date | Nov 26, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $45,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, filing-update
TL;DR
CG Oncology moved its HQ and might be shuffling execs/board.
AI Summary
CG Oncology, Inc. announced on November 22, 2025, a change in its principal executive offices to 400 Spectrum Center Drive, Suite 2040, Irvine, California. This filing also indicates potential changes related to directors, officers, and compensatory arrangements, though specific details are not provided in this excerpt.
Why It Matters
A change in principal executive offices can signal operational shifts or growth, while potential changes in leadership or compensation arrangements are key indicators of internal strategy and governance.
Risk Assessment
Risk Level: low — The filing primarily reports a change of address and potential administrative changes, which are typically low-risk events.
Key Players & Entities
- CG Oncology, Inc. (company) — Registrant
- 400 Spectrum Center Drive, Suite 2040, Irvine, California (location) — New Principal Executive Offices
- November 22, 2025 (date) — Date of earliest event reported
FAQ
What is the new address for CG Oncology, Inc.'s principal executive offices?
The new address is 400 Spectrum Center Drive, Suite 2040, Irvine, California, 92618.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is November 22, 2025.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is CG Oncology, Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number is 37-1611499.
What are the main items of information covered by this 8-K filing?
The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Filing Stats: 688 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2025-11-26 07:30:25
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share CGON The Nasdaq Global Se
- $45,000 — rogram, Ms. Rossi will receive a fee of $45,000 per calendar year of service on the Boa
Filing Documents
- ck0001991792-20251122.htm (8-K) — 48KB
- 0001193125-25-298160.txt ( ) — 159KB
- ck0001991792-20251122.xsd (EX-101.SCH) — 26KB
- ck0001991792-20251122_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CG Oncology, Inc. Date: November 26, 2025 By: /s/ Josh Patterson Name: Josh Patterson Title: General Counsel and Chief Compliance Officer